Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Benign Prostatic Hyperplasia Medications | New policy |
| Aug 2, 2026 | Point32Health | Baxdela (delafloxacin) tablet | New policy |
| Aug 2, 2026 | Point32Health | Baclofen (Ozobax) Oral Solution | New policy |
| Aug 2, 2026 | Point32Health | Austedo (deutetrabenazine) | New policy |
| Aug 2, 2026 | Point32Health | Attruby (acoramidis) | New policy |
| Aug 2, 2026 | Point32Health | Attruby (acoramidis) | New policy |
| Aug 2, 2026 | Point32Health | Attention Deficit Hyperactivity Disorder Drugs | New policy |
| Aug 2, 2026 | Point32Health | Attention Deficit Hyperactivity Disorder (ADHD) Medications - Non-Stimulants | New policy |
| Aug 2, 2026 | Point32Health | Astagraf XL (tacrolimus extended-release) | New policy |
| Aug 2, 2026 | Point32Health | Asmanex Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | Aqvesme (mitapivat) | New policy |
| Aug 2, 2026 | Point32Health | Anzupgo (delgocitinib cream) | New policy |
| Aug 2, 2026 | Point32Health | Antiviral Agents, Topical | New policy |
| Aug 2, 2026 | Point32Health | Antiseizure Medications | New policy |
| Aug 2, 2026 | Point32Health | Antipsychotic Medications | New policy |
| Aug 2, 2026 | Point32Health | Antipsychotic Medications | New policy |
| Aug 2, 2026 | Point32Health | Antineoplastics | New policy |
| Aug 2, 2026 | Point32Health | Antineoplastics | New policy |
| Aug 2, 2026 | Point32Health | Antihypertensive Medications | New policy |
| Aug 2, 2026 | Point32Health | Antifungal Medications, Topical | New policy |
| Aug 2, 2026 | Point32Health | Antidepressants | New policy |
| Aug 2, 2026 | Point32Health | Antidepressant Medications | New policy |
| Aug 2, 2026 | Point32Health | Anticonvulsants/Mood Stabilizers | New policy |
| Aug 2, 2026 | Point32Health | Anti-Obesity Medications | New policy |
| Aug 2, 2026 | Point32Health | Anti-Infective Medications, Ophthalmic | New policy |
| Aug 2, 2026 | Point32Health | Anti-Emetic Medications | New policy |
| Aug 2, 2026 | Point32Health | Anti-Allergy Medications, Ophthalmic | New policy |
| Aug 2, 2026 | Point32Health | Analeptic CNS Stimulants: Armodafinil and Modafinil | New policy |
| Aug 2, 2026 | Point32Health | Allergy Immunotherapy | New policy |
| Aug 2, 2026 | Point32Health | Alhemo (concizumab-mtci) | New policy |
| Aug 2, 2026 | Point32Health | Akynzeo (netupitant/palonosetron) | New policy |
| Aug 2, 2026 | Point32Health | Adbry (tralokinumab-ldrm) | New policy |
| Aug 2, 2026 | Point32Health | Adalimumab Products | New policy |
| Aug 2, 2026 | Point32Health | Actimmune (interferon gamma-1b) | New policy |
| Aug 2, 2026 | Point32Health | Actemra (tocilizumab) Subcutaneous | New policy |
| Aug 2, 2026 | Point32Health | Acromegaly Agents for Self-administration | New policy |
| Aug 2, 2026 | Point32Health | Acne and Rosacea Medications | New policy |
| Aug 2, 2026 | Point32Health | Accrufer (ferric maltol) | New policy |
| Aug 2, 2026 | Point32Health | Whole Genome Sequencing | New policy |
| Aug 2, 2026 | Point32Health | Vitamin D Screening and Testing | New policy |
| Aug 2, 2026 | Point32Health | Vitamin B12 Screening and Testing | New policy |
| Aug 2, 2026 | Point32Health | Video Capsule Endoscopy | New policy |
| Aug 2, 2026 | Point32Health | Vertebroplasty and Kyphoplasty | New policy |
| Aug 2, 2026 | Point32Health | Urine Drug Testing | New policy |
| Aug 2, 2026 | Point32Health | Upper Limb Prostheses | New policy |
| Aug 2, 2026 | Point32Health | Upper Gastrointestinal Endoscopy (Esophagogastroduodenoscopy, EGD) | New policy |
| Aug 2, 2026 | Point32Health | UVB Home Units for Skin Disease | New policy |
| Aug 2, 2026 | Point32Health | Tumor Treating Fields | New policy |
| Aug 2, 2026 | Point32Health | Transcranial Magnetic Stimulation (rTMS) | New policy |
| Aug 2, 2026 | Point32Health | Transcranial Magnetic Stimulation (TMS) for Tufts Health One Care, Tufts Medicare Preferred and Tufts Health Plan Senior Care Options | New policy |